Preoperative chemoradiotherapy for oesophageal cancer: A systematic review and meta-analysis

Gut

Volumn 53, Issue 7, 2004, Pages 925-930

  Fiorica, F ^b,c   Di Bona, D ^d,e   Schepis, F ^b   Licata, A ^d   Shahied, L ^f   Venturi, A ^b   Falchi, A M ^b   Craxi A ^d   Camma C ^a,d,e  

^a University of Modena e Reggio Emilia ^*  (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c Azienda Ospedaliero Sant'Anno U   (Italy)

^d UNIVERSITY OF PALERMO   (Italy)

^e CNR Consiglio Nazionale delle Ricerche   (Italy)

^f FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; FLUOROURACIL; VINBLASTINE;

ADJUVANT CHEMOTHERAPY; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; CONFIDENCE INTERVAL; DATA ANALYSIS; ESOPHAGUS CANCER; HUMAN; INTERMETHOD COMPARISON; META ANALYSIS; METASTASIS; MULTIMODALITY CANCER THERAPY; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZATION; REVIEW; TREATMENT OUTCOME;

CHEMOTHERAPY, ADJUVANT; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; HUMANS; POSTOPERATIVE COMPLICATIONS; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 3042584502     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2003.025080     Document Type: Review

References (35)

1. The World Health Report 1997. Geneva: World Health Organization, 1997.
2. Faivre J, Forman D, Esteve J, et al. Survival of patients with oesophageal and gastric cancers in Europe. Eur J Cancer 1998;34:2167-75.
3. Kelsen DP, Bains M, Burt M. Neoadjuvant chemotherapy and surgery of cancer of the esophagus. Semin Surg Oncol 1990;6:268-73.
4. Muller JM, Erasmi H, Stelzner M, et al. Surgical therapy of oesophogeal carcinoma. Br J Surg 1990;77:845-57.
5. Daily JM, Karnell LH, Menck HR. National Cancer Database report on oesophageal carcinoma. Cancer 1996;78:1820-8.
6. Hulscher JB, van Sandick JW, de Boer AG, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002;347:1662-9.
7. Arnott SJ, Duncan W, Gignoux M, et al. Preoperative radiotherapy for oesophageal carcinoma (Cochrane Review). London: The Cochrane Library, 2003 (issue 4)).
8. Kelsen DP, Ginsberg R, Pajak TF, et al. Chemotherapy followed by surgery compared with surgery alone for localized oesophageal cancer. N Engl J Med 1998;339:1979-84.
9. Law S, Fok M, Chow S, et al. Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial. J Thorac Cardiovasc Surg 1997;114:210-17.
10. Kok TC, van Lanschot J, Siersema PD, for the Rotterdam Oesophageal Tumor Study Group, et al. Neoadjuvant chemotherapy in operable oesophageal squamous cell cancer: final repart of a phase III multicenter randomized controlled trial. Proc Am Soc Clin Oncol 1997;16:A984.
11. Medical Research Council Ooesophageal Cancer Working Party. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 2002;359:1727-33.
12. Nygaard K, Hagen S, Hansen HS, et al. Pre-operative radiotherapy prolongs survival in operable oesophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in oesophageal cancer. World J Surg 1992;16:1104-10.
13. Le Prise E, Etienne PL, Meunier B, et al. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 1994;73:1779-84.
14. Apinop C, Puttisak P, Preecha N. A prospective study of combined therapy in oesophageal cancer. Hepatogastroenterology 1994;41:391-3.
15. Walsh TN, Noonan N, Hollywood D, et al. A comparison of multimodal therapy and surgery for oesophageal adenocarcinoma. N Engl J Med 1996;335:462-7.
16. Basset JF, Gignoux M, Triboulet JP, et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 1997;337:161-7.
17. Urba SG, Orringer MB, Turrisi A, et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional oesophageal carcinoma. J Clin Oncol 2001;119:305-13.
18. Walsh TN, Noonan N, Hollywood D, et al. Multimodality therapy versus surgery for oesophageal adenocarcinoma. A prospective randomised trial. Gastroenterology 1996;110(suppl 4):A611.
19. Ackland S, Burmeisteister BH, Smithers BM, et al. Preoperative chemoradiation (CT/RT) versus surgery alone for resectable carcinoma of esophagus: an Australasian randomised study. Proc Am Soc Clin Oncol 1998;17:A1095.
20. Burmeister BH, Smithers BM, Fitzgerald L, et al. A randomized phase III trial of preoperative chemoradiation followed by surgery (CR-S) versus surgery alone (S) for localized resectable cancer of the esophagus. Proc Am Soc Clin Oncol 2002;20:A518.
21. Walsh TN, Noonan N, Hollywood D, et al. Multimodality therapy versus surgery for oesophageal adenocarcinoma. A prospective randomised trial. Gastroenterology 1995;108(suppl 4):A550.
22. Urba S, Orringer M, Turrisi A, et al. A randomized trial comparing surgery (S) to preoperative concomitant chemoradiation plus surgery in patients (pts) with resectable oesophageal cancer (CA): updated analysis. Pro Am Soc Clin Oncol, 1997;16:A983.
23. Moher D, Cook DJ, Eastwood S, et al. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999;27:1896-900.
24. Nicolucci A, Grilli R, Alexanian AA, et al. Quality evolution and clinical implications of randomized, controlled trials on the treatment of lung cancer: A lost opportunity for meta-analysis. JAMA 1989;262:2101-7.
25. Juni P, Witschi A, Bloch R, et al. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 1999;282:1054-60.
26. Esophagus. In: American Joint Committee on Cancer: AJCC cancer Staging Manual, 5th edn. Philadelphia: Lippincott-Raven Publishers 1997:65-69.
27. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
28. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-48.
29. Jaeschke R, Oxman AD, Guyatt GH. To what extent do congestive heart failure patient in sinus rhythm benefit from digoxin therapy? A systematic overview and meta-analysis. Am J Med 1990;88:279-86.
30. Barendsen GW. Dase fractionation, dose rate and iso-effect relationships for normal tissue responses. Int J Radiat Oncol Biol Phys 1982;8:1981-7.
31. Hedges LV, Olkin I. Statistical methods for meta-analysis. New York: Academic Press, 1985.
32. Yusuf S, Peto R, Lewis J, et al. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985;27:335-71.
33. Devesa SS, Blot WJ, Fraumeni JF jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998;83:2049-53.
34. Wayman J, Forman D, Griffin SM. Monitoring the changing pattern of esophago-gastric cancer: data from a UK regional cancer registry. Cancer Causes Control 2001;12:943-9.
35. Follman DA, Proschan MA. Valid inference in random effects meta-analysis. Biometrics 1999;55:732-7.